Pilot Study of Human Recombinant Hyaluronidase–Enhanced Subcutaneous Hydration and Opioid Administration for Sickle Cell Disease Acute Pain Episodes

Marcelo SandovalMarcelo Sandoval, MD, is Assistant Professor, Department of Emergency Medicine, MD Anderson Cancer Center, Houston, Texas, USA. Patricia Coleman, RN, BSN, is with the Emergency Department, Beth Israel Medical Center, New York, New York, USA. Rahim Govani, MD, is Attending Physician, Department of Emergency Medicine, Kaiser Permanente Medical Center, Downey, California, USA. Saima Siddiqui, MPH, is Clinical Research Manager, Children's Hospital at Montefiore, Bronx, New York, USA. Knox H. Todd, MD, MPH, is Professor and Chair, Department of Emergency Medicine, MD Anderson Cancer Center, Houston, Texas, USA.Correspondence[email protected]

Patricia ColemanMarcelo Sandoval, MD, is Assistant Professor, Department of Emergency Medicine, MD Anderson Cancer Center, Houston, Texas, USA. Patricia Coleman, RN, BSN, is with the Emergency Department, Beth Israel Medical Center, New York, New York, USA. Rahim Govani, MD, is Attending Physician, Department of Emergency Medicine, Kaiser Permanente Medical Center, Downey, California, USA. Saima Siddiqui, MPH, is Clinical Research Manager, Children's Hospital at Montefiore, Bronx, New York, USA. Knox H. Todd, MD, MPH, is Professor and Chair, Department of Emergency Medicine, MD Anderson Cancer Center, Houston, Texas, USA.

Rahim GovaniMarcelo Sandoval, MD, is Assistant Professor, Department of Emergency Medicine, MD Anderson Cancer Center, Houston, Texas, USA. Patricia Coleman, RN, BSN, is with the Emergency Department, Beth Israel Medical Center, New York, New York, USA. Rahim Govani, MD, is Attending Physician, Department of Emergency Medicine, Kaiser Permanente Medical Center, Downey, California, USA. Saima Siddiqui, MPH, is Clinical Research Manager, Children's Hospital at Montefiore, Bronx, New York, USA. Knox H. Todd, MD, MPH, is Professor and Chair, Department of Emergency Medicine, MD Anderson Cancer Center, Houston, Texas, USA.

Saima SiddiquiMarcelo Sandoval, MD, is Assistant Professor, Department of Emergency Medicine, MD Anderson Cancer Center, Houston, Texas, USA. Patricia Coleman, RN, BSN, is with the Emergency Department, Beth Israel Medical Center, New York, New York, USA. Rahim Govani, MD, is Attending Physician, Department of Emergency Medicine, Kaiser Permanente Medical Center, Downey, California, USA. Saima Siddiqui, MPH, is Clinical Research Manager, Children's Hospital at Montefiore, Bronx, New York, USA. Knox H. Todd, MD, MPH, is Professor and Chair, Department of Emergency Medicine, MD Anderson Cancer Center, Houston, Texas, USA.

Knox H. ToddMarcelo Sandoval, MD, is Assistant Professor, Department of Emergency Medicine, MD Anderson Cancer Center, Houston, Texas, USA. Patricia Coleman, RN, BSN, is with the Emergency Department, Beth Israel Medical Center, New York, New York, USA. Rahim Govani, MD, is Attending Physician, Department of Emergency Medicine, Kaiser Permanente Medical Center, Downey, California, USA. Saima Siddiqui, MPH, is Clinical Research Manager, Children's Hospital at Montefiore, Bronx, New York, USA. Knox H. Todd, MD, MPH, is Professor and Chair, Department of Emergency Medicine, MD Anderson Cancer Center, Houston, Texas, USA.

ABSTRACT

The objective of this study was to determine the feasibility of protocol-driven human recombinant hyaluronidase (rHuPH20)-enhanced subcutaneous (SC) hydration and opioid administration in adults presenting to the emergency department (ED) with sickle cell disease acute pain episodes (SCDAPE). Adults with SCDAPE were given 150 U of rHuPH20 and normal saline subcutaneously. Opioids were administered SC every 15 minutes for 4 hours until numerical rating scale (NRS) pain intensity scores fell to <5, or Ramsay Sedation Scores were >4. Pain intensity and pain relief were recorded hourly. Total morphine equivalents and fluid volume, total pain relief (TOTPAR), patient- and physician-perceived global efficacy, patient-perceived global SC needle discomfort, physician-rated ease of needle placement, and adverse effects were noted. Ten patients (6 males, 4 females), mean age 32.9 years (23–56 years) completed the trial. Mean pain intensity scores fell 25% (from 9.2 to 6.9) from baseline and mean 4-hour TOTPAR score was 4 (maximum: 16). A mean total of 119 mg (70–170 mg) morphine equivalents and 846 mL (200–1650 mL) normal saline were administered. Mean patient and physician global perceived efficacy ratings were 3.4 and 4.2 (of 5). Patient global discomfort of SC needle presence was 2.7 (of 10), and ease of needle placement was physician rated at 4 (of 4; easiest). Patients experienced mild swelling and stinging at the SC site, and no infusion required discontinuation. The authors conclude that rHuPH20-enhanced subcutaneous hydration and opioid administration appear feasible from this pilot study. These results need confirmation in a controlled clinical trial.

KEYWORDS :

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Pilot Study of Human Recombinant Hyaluronidase–Enhanced Subcutaneous Hydration and Opioid Administration for Sickle Cell Disease Acute Pain Episodes

Information for

Open access

Opportunities

Help and information

Pilot Study of Human Recombinant Hyaluronidase–Enhanced Subcutaneous Hydration and Opioid Administration for Sickle Cell Disease Acute Pain Episodes

ABSTRACT

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature